Figure 2. Plasma concentration of VWF and propeptide in Plasmodium falciparum cerebral malaria patients during and after treatment.

Plasma levels of VWF and VWF propeptide were measured at admission, 2 days and 30 days post-treatment in a cohort of retinopathy positive children with cerebral malaria (Friedman Test, *P<0.05). Dotted lines indicate median levels in local healthy Malawian adults.